Cyclerion Therapeutics, Inc.Recognition Bonus Agreement • March 5th, 2024 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This letter agreement (this “Agreement”) between you and Cyclerion Therapeutics, Inc. (the “Company”) amends and restates the prior retention bonus letter agreement, dated October 3, 2022, between you and the Company, with respect to your opportunity to earn a Recognition Bonus (as defined below). The Company is offering you this opportunity in recognition of your importance to the continued success of the Company.
CURIS, INC.Recognition Bonus Agreement • November 3rd, 2016 • Curis Inc • Biological products, (no disgnostic substances) • Massachusetts
Curis, Inc. (the “Company”) appreciates your many years of service in varying roles including as Chief Executive Officer, President, Vice-Chairman of the Board of Directors (the “Board”) and as a consultant. In recognition of such service, this letter agreement will memorialize certain arrangements between the Company and you, as well as resolve any outstanding issues there may be. This Agreement may be accepted by you by providing an executed agreement which is received by the Company by no later than August 31, 2016, after which time the Agreement and the offer embodied within it, shall be effectively withdrawn.
